Anti-PD-1 antibody (Tislelizumab) combined with gemcitabine and oxaliplatin for extranodal NK/T-cell lymphoma failing asparaginase: A multicenter phase II trial
Titel:
Anti-PD-1 antibody (Tislelizumab) combined with gemcitabine and oxaliplatin for extranodal NK/T-cell lymphoma failing asparaginase: A multicenter phase II trial
Auteur:
Ding, Kaiyang Liu, Hailing Sheng, Lixia Ma, Jie Zhang, Xiaohui Huang, Hongming Shi, Wei Peng, Hongling Cao, Lei Wu, Wei Li, Jianyong Fan, Lei